FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy

FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality

(2012) Victoria Shalhoub et al.   JOURNAL OF CLINICAL INVESTIGATION

Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals

(2012) Joachim H. Ix et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Relationship of Fibroblast Growth Factor 23 with Left Ventricle Mass Index and Coronary Calcificaton in Chronic Renal Disease

(2012) Abdulkadir Unsal et al.   KIDNEY & BLOOD PRESSURE RESEARCH

FGF23 production by osteocytes

(2012) Lynda F. Bonewald et al.   PEDIATRIC NEPHROLOGY

C-terminal FGF23 is a strong predictor of survival in systolic heart failure

(2012) Damien Gruson et al.   PEPTIDES

Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease

(2011) Eric N. Taylor et al.   AMERICAN HEART JOURNAL

Store-operated calcium entry is present in HL-1 cardiomyocytes and contributes to resting calcium

(2011) Chad D. Touchberry et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

TRPC Channels As Effectors of Cardiac Hypertrophy

(2011) Petra Eder et al.   CIRCULATION RESEARCH

Junctophilin-2 Expression Silencing Causes Cardiocyte Hypertrophy and Abnormal Intracellular Calcium-Handling

(2011) Andrew P. Landstrom et al.   Circulation-Heart Failure

The phosphatonin fibroblast growth factor 23 links calcium–phosphate metabolism with left-ventricular dysfunction and atrial fibrillation

(2011) Sarah Seiler et al.   EUROPEAN HEART JOURNAL

Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure

(2011) Max Plischke et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Relationship of serum fibroblast growth factor 23 with cardiovascular disease in older community-dwelling women

(2011) Mansi Dalal et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease

(2011) Jason R Stubbs et al.   JOURNAL OF BONE AND MINERAL RESEARCH

FGF23 induces left ventricular hypertrophy

(2011) Christian Faul et al.   JOURNAL OF CLINICAL INVESTIGATION

Unraveling the secrets of a double life: Contractile versus signaling Ca2+ in a cardiac myocyte

(2011) Sanjeewa A. Goonasekera et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart

(2011) M. L. Ford et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Renal Protective Effects of Aliskiren Beyond Its Antihypertensive Property in a Mouse Model of Progressive Fibrosis

(2010) O. Gross et al.   AMERICAN JOURNAL OF HYPERTENSION

Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype

(2010) Hua Li et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Regulation of Phosphate Homeostasis by PTH, Vitamin D, and FGF23

(2010) Clemens Bergwitz et al.   Annual Review of Medicine

Association Between Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Maintenance Hemodialysis Patients

(2010) Kazuaki Negishi et al.   CIRCULATION JOURNAL

Phosphatidylinositol 3,5-Bisphosphate (PI(3,5)P2) Potentiates Cardiac Contractility via Activation of the Ryanodine Receptor

(2010) Chad D. Touchberry et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Transplantation of expanded bone marrow-derived very small embryonic-like stem cells (VSEL-SCs) improves left ventricular function and remodelling after myocardial infarction

(2010) Ewa K. Zuba-Surma et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Both FGF23 and extracellular phosphate activate Raf/MEK/ERK pathway via FGF receptors in HEK293 cells

(2010) Miwa Yamazaki et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients

(2009) Heng Jung Hsu et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

(2009) Majd A.I. Mirza et al.   ATHEROSCLEROSIS

Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease

(2009) Renata C. Pereira et al.   BONE

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

(2009) Orlando M. Gutiérrez et al.   CIRCULATION

Heme Oxygenase-1 Inhibits Pro-Oxidant Induced Hypertrophy in HL-1 Cardiomyocytes

(2009) Keith R. Brunt et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Cardiac hypertrophy: Targeting Raf/MEK/ERK1/2-signaling

(2009) Kristina Lorenz et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Inhibition of Thromboxane A2-Induced Arrhythmias and Intracellular Calcium Changes in Cardiac Myocytes by Blockade of the Inositol Trisphosphate Pathway

(2009) M. J. Wacker et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Relationship between circulating FGF23 and total body atherosclerosis in the community

(2009) Majd A. I. Mirza et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Blebbistatin extends culture life of adult mouse cardiac myocytes and allows efficient and stable transgene expression

(2008) Zhyldyz Kabaeva et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study

(2008) Benjamin Dieplinger et al.   KIDNEY INTERNATIONAL

Calcium Cycling and Signaling in Cardiac Myocytes

(2007) Donald M. Bers   Annual Review of Physiology